Concepedia

Rezvan Rafi

RR

3

Publications

98

Citations

3

H-Index

2009

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Rezvan Rafi is an author at Beth Israel Deaconess Medical Center specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2009–2012

3

Publications

3

Drug-induced liver injury following positive drug rechallenge

Julie I. Papay, Dawn C. Clines, Rezvan Rafi et al. · Regulatory Toxicology and Pharmacology · 2009 · 76 citations

, , +5

Phase I, open-label study of olaparib plus cisplatin in patients with advanced solid tumors.

Judith Balmañà, Nadine Tung, Steven J. Isakoff et al. · Journal of Clinical Oncology · 2012 · 12 citations

, , +16

A Phase I Dose-Escalation Study of SR271425, an Intravenously Dosed Thioxanthone Analog, Administered Weekly in Patients With Refractory Solid Tumors

A. Craig Lockhart, Emiliano Calvo, Anthony W. Tolcher et al. · American Journal of Clinical Oncology · 2009 · 10 citations

Rows per page

1–3 of 3